Overall survival of children and adolescents with mature B cell non-Hodgkin lymphoma who had refractory or relapsed disease during or after treatment with FAB/LMB 96: A report from the FAB/LMB 96 study group
published in: British Journal of Haematology
date of publication: 2018-07-09
main subject: non-Hodgkin lymphoma
Cites articles 49
Date
Title
Article - wd:Q89469635